VYNE Therapeutics Inc. — SEC S-4 Filing
Yarrow Bioscience→Shanghai Scizeng Medical Technology
Mar 31, 2026
Track acquisitions, mergers, and investments in the healthcare sector.
Tentt has tracked 666 healthcare M&A deals, with 225 transactions recorded in the last 30 days. The most active sub-sectors include Healthcare Services Other (163), Pharmacy (135), Medical Devices (106), Healthcare It (40).
California leads with 55 deals, followed by New York and Florida. Strategic accounts for 68% of buyer activity in this sector, with Private Equity (145), Public Company (27) also active.
The most recent transaction tracked is "Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18."
Yarrow Bioscience→Shanghai Scizeng Medical Technology
Mar 31, 2026
ImmunityBio
Mar 31, 2026
Jubilant Ingrevia→Remidex Pharma
Mar 30, 2026
Kailera Therapeutics
Mar 30, 2026
Vision Innovation Partners→Frederick Eye Institute
Mar 30, 2026
Prime Healthcare Foundation→Central Maine Healthcare
Mar 30, 2026
Kain Capital→White Wilson Medical Center
Mar 30, 2026
Medtronic→Scientia Vascular
Mar 30, 2026
Aurinia Pharmaceuticals→Kezar Life Sciences
Mar 30, 2026
VIP→Frederick Eye Institute
Mar 30, 2026
Marvel Biosciences
Mar 30, 2026
Aurinia Pharma→Kezar Life Sciences
Mar 30, 2026
Kinderhook Industries→Enhabit
Mar 30, 2026
Boston Scientific→Penumbra
Mar 30, 2026
Universal Health Services→Talkspace
Mar 28, 2026
Florida State University→Tallahassee Memorial HealthCare
Mar 27, 2026
Pediatrix Medical Group→Tennessee Maternal-Fetal Medicine
Mar 27, 2026
Otsuka→Transcend
Mar 27, 2026
Cencora→EyeSouth Retina
Mar 27, 2026
Optima Healthcare→PAM Healthcare
Mar 27, 2026